Risk Management Plans: Implementation of the New Pharmacovigilance Legislation in Mexico

被引：0

作者：

Duran, H. ^{[1
]}

Alatorre, R. ^{[2
]}

Lara, O. ^{[1
]}

机构：

[1] COFEPRIS, RMP Coordinat, Mexico City, DF, Mexico

[2] COFEPRIS, CEMAR, Mexico City, DF, Mexico

来源：

DRUG SAFETY | 2018年 / 41卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

ISoP18-144

引用

页码：1244 / 1245

页数：2

共 50 条

[31] The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development
Callreus, Torbjorn
DRUG SAFETY, 2011, 34 (06) : 529 - 530
[32] EU’s new pharmacovigilance legislation: first EMA report
Reactions Weekly, 2014, 1501 (1) : 4 - 4
[33] The LAWA Recommendations for the Establishment of Flood Risk Management Plans and their Implementation in the Nahe Catchment
Worreschk, Bernd
Schernikau, Ralf
WASSERWIRTSCHAFT, 2010, 100 (11) : 42 - 46
[34] Better awareness and implementation of pharmacovigilance and risk management planning is needed within the European pharmaceutical industry
Ingate, S.
Tranter, D.
Banerjee, A.
Hobbs, A.
DRUG SAFETY, 2006, 29 (10) : 928 - 928
[35] Analysis of the Risk Management Plans Submitted to the Rational Drug Use and Pharmacovigilance Department at JFDA (2014-2017)
Jaber, J.
DRUG SAFETY, 2018, 41 (11) : 1125 - 1125
[36] New epidemiology requirements for risk management plans - Experiences and challenges
Saddier, Patricia
Perez-Gutthann, Susana
Stemhagen, Annette
Haas, Joanna
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S211 - S211
[37] Global risk management: New strategies for implementation
Smith, SC
MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: STRATEGIES OF PREVENTION OF CORONARY HEART DISEASE, CARDIAC FAILURE, AND STROKE, 1998, 12 : 349 - 355
[38] Wales plans new legislation to control dangerous dogs
不详
VETERINARY RECORD, 2012, 170 (07) : 167 - 167
[39] The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development Reply
Borg, John-Joseph
Aislaitner, George
Pirozynski, Michal
Mifsud, Stephen
DRUG SAFETY, 2011, 34 (06) : 530 - 531
[40] Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures
Francisca, Reynold D. C.
Zomerdijk, Inge M.
Sturkenboom, Miriam C. J. M.
Straus, Sabine M. J. M.
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (10) : 975 - 982

← 1 2 3 4 5 →